Similarly, the risk of infection with Fc receptor homolog 5 (FcRH5)-targeting BsAb resulted lower (54% any grade; 19% grade ≥ 3), likely due to less severe neutropenia (31% all grades; 28% grade ≥ 3) and hypogammaglobulinemia [101]. Here, FCRL5 is linked to neutropenia.